AZN
AstraZeneca PLC
Stock
$156.90−0.80 (−0.51%)Close Oct 2, 2026
- Revenue, 2025
- $58.7B
- YoY, 2025
- +8.6%
- 5-year CAGR
- +17.2%
- 10-year CAGR
- +9.0%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $58.7B | +8.6% |
| 2024 | $54.1B | +18.0% |
| 2023 | $45.8B | +3.3% |
| 2022 | $44.4B | +18.5% |
| 2021 | $37.4B | +40.6% |
| 2020 | $26.6B | +9.2% |
| 2019 | $24.4B | +10.4% |
| 2018 | $22.1B | −1.7% |
| 2017 | $22.5B | −2.3% |
| 2016 | $23.0B | −6.9% |
| 2015 | $24.7B | — |